Luxembourg: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Luxembourg

The Luxembourg prophylactic medicaments containing insulin market shrank to $X in 2022, remaining constant against the previous year. The market value increased at an average annual rate of +3.3% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Prophylactic medicaments containing insulin consumption peaked at $X in 2018; however, from 2019 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Luxembourg

In value terms, prophylactic medicaments containing insulin production fell modestly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +2.5% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of 28%. Over the period under review, production attained the maximum level at $X in 2014; however, from 2015 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Luxembourg

For the third consecutive year, Luxembourg recorded growth in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, which increased by 2% to X tons in 2022. Overall, exports continue to indicate a significant increase. The pace of growth was the most pronounced in 2021 with an increase of 608,550%. Over the period under review, the exports reached the peak figure in 2022 and are expected to retain growth in the near future.

In value terms, prophylactic medicaments containing insulin exports shrank rapidly to $X in 2022. Over the period under review, exports showed a significant increase. The most prominent rate of growth was recorded in 2021 when exports increased by 1,538,357% against the previous year. As a result, the exports attained the peak of $X, and then shrank markedly in the following year.

Exports by Country

Belgium (X tons) was the main destination for prophylactic medicaments containing insulin exports from Luxembourg, with a 99% share of total exports. It was followed by the Netherlands (X kg), with a 0.9% share of total exports.

From 2015 to 2022, the average annual rate of growth in terms of volume to Belgium totaled +283.9%.

In value terms, Belgium ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Luxembourg, comprising 99% of total exports. The second position in the ranking was held by the Netherlands ($X), with a 1.2% share of total exports.

From 2015 to 2022, the average annual growth rate of value to Belgium totaled +344.3%.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, shrinking by -22.3% against the previous year. Over the period under review, the export price, however, showed prominent growth. The most prominent rate of growth was recorded in 2020 an increase of 952%. Over the period under review, the average export prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices stood at a somewhat lower figure.

Average prices varied somewhat for the major export markets. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Belgium amounted to $X per ton.

From 2015 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Oman (+105.5%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Luxembourg

For the third consecutive year, Luxembourg recorded growth in purchases abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 14% to X tons in 2022. Over the period under review, imports showed a significant increase. The most prominent rate of growth was recorded in 2021 with an increase of 8,158%. Over the period under review, imports reached the peak figure in 2022 and are likely to see gradual growth in the near future.

In value terms, prophylactic medicaments containing insulin imports reduced notably to $X in 2022. In general, imports showed significant growth. The most prominent rate of growth was recorded in 2021 with an increase of 26,725% against the previous year. As a result, imports reached the peak of $X, and then reduced markedly in the following year.

Imports by Country

In 2022, Belgium (X tons) was the main supplier of prophylactic medicaments containing insulin to Luxembourg, accounting for a 91% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Belgium exceeded the figures recorded by the second-largest supplier, France (X tons), more than tenfold.

From 2012 to 2022, the average annual growth rate of volume from Belgium amounted to +72.5%.

In value terms, Belgium ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Luxembourg, comprising 99% of total imports. The second position in the ranking was held by France ($X), with a 0.9% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from Belgium stood at +72.1%.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, which is down by -27% against the previous year. Overall, the import price showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2021 an increase of 225% against the previous year. The import price peaked at $X per ton in 2015; however, from 2016 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Belgium ($X per ton), while the price for France stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Belgium (-0.2%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :